Roy Galvin
Fortune : 5 M $ au 31/10/2026
Fortune : 5 M $ au 31/10/2026
Roy Galvin is currently Chief Executive Officer at Cardiva Medical, Inc. Mr. Galvin is also Chief Commercial Officer & Executive VP at Haemonetics Corp., a position starting in 2025.
Formerly, Mr. Galvin was Vice President-Sales at Medtronic Xomed, Inc.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/10/2026 | 39 805 ( 0,09% ) | 5 M $ | 31/10/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| HAEMONETICS CORPORATION | Corporate Officer/Principal | 01/10/2022 |
Cardiva Medical, Inc.
Cardiva Medical, Inc. Medical SpecialtiesHealth Technology Operates as a medical device company that develops vascular closure for patients, hospitals and physicians | Directeur Général | - |
| Sociétés | Poste | Fin |
|---|---|---|
Medtronic Xomed, Inc.
Medtronic Xomed, Inc. Electronic Equipment/InstrumentsElectronic Technology Manufactures and distributes surgical products | Sales & Marketing | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 3 |
|---|---|
Haemonetics Corp.
Haemonetics Corp. Medical SpecialtiesHealth Technology Designs, manufactures, markets and services blood processing systems | Health Technology |
Medtronic Xomed, Inc.
Medtronic Xomed, Inc. Electronic Equipment/InstrumentsElectronic Technology Manufactures and distributes surgical products | Electronic Technology |
Cardiva Medical, Inc.
Cardiva Medical, Inc. Medical SpecialtiesHealth Technology Operates as a medical device company that develops vascular closure for patients, hospitals and physicians | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national